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estrictive Annuloplasty for
schemic Mitral Regurgitation
oo Little or Too Much?*
homas H. Marwick, MBBS, PHD, FACC
risbane, Australia
schemic mitral regurgitation (MR) remains one of the
ajor unresolved issues in the management of ischemic
eart disease. This entity is both common (occurring in 20%
o 25% of patients following myocardial infarction and 50%
f post-infarct patients with heart failure) (1) and fatal
increasing mortality even when mild) (2). The mecha-
isms, which have been well documented, are predominantly
entricular rather than valvular. They include displacement of
he posterior papillary muscle, ventricular enlargement with
ncreased ventricular sphericity displacing both papillary mus-
les, annular enlargement, papillary muscle dyssynchrony, and
educed leaflet closing force from left ventricular (LV) dysfunc-
ion. All of these functional phenomena may be counterbal-
nced by changes in LV function and loading, causing the
everity of the lesion to vary over time (1).
See page 1692
Attempts to control ischemic MR surgically have been
imited by the available tools. Given the contribution of
entricular function, myocardial revascularization is almost
lways a component of the intervention. However, there is
ore evidence of an association of cardiac scarring with the
egree of MR than there is of cardiac scarring being
ssociated with the typical valve morphology of ischemic
R (e.g., increased tenting area) (3), and the contributions
f ischemia and myocardial viability are not well defined.
itral valve replacement is associated with high surgical risk
nd the possibility of deterioration of LV function. Restric-
ive mitral annuloplasty, used in the management of isch-
mic MR for more than a decade (4), involves the insertion
f an undersized annuloplasty ring. This has the effect of
educing the septal to lateral dimension of the valve,
mproving the apposition of the leaflets. The technique
ppears to be effective in the short term; indeed, patients
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.o
From the Princess Alexandra Hospital and University of Queensland School of
edicine, Brisbane, Australia.ith residual MR show significantly worse outcome than
hose with successful operations. However, severe MR may
ecur in up to 30% of patients in the course of the first year
5) because of ongoing LV remodeling, particularly involv-
ng the posterior wall (6,7).
To this problem of recurrent MR, Magne et al. (8) have
emonstrated in this issue of the Journal that restrictive
nnuloplasty may also induce functional mitral stenosis. In
his study of 24 patients with ischemic MR and 20 control
atients with coronary artery disease, matched for age,
ender, and LV ejection fraction, patients were studied at
est, after dobutamine stress, and in a subgroup after
xercise stress. In contrast with the control group, annulo-
lasty patients demonstrated an increase of resting mitral
radients and pulmonary artery pressure after surgery and a
eduction of valve area. Most of the investigated patients
howed these changes, with 50% having a valve area of
1.5 cm2 and 40% having a peak gradient of 15 mm
g. The increase of gradients following stress was substan-
ially larger in the annuloplasty group, with a much smaller
ncrease of valve area with stress. These differences were
agnified in the subgroup also studied with exercise stress.
inally, the resting gradients correlated with the pulmonary
rtery pressure and inversely correlated with exercise capac-
ty, as measured by the 6-min walk test. The authors
onclude that restrictive annuloplasty creates functional
itral stenosis, associated with pulmonary hypertension and
educed exercise capacity.
The investigators have produced a valuable addition to
ublished data regarding a complex problem that is chal-
enging to study because of issues relating to the quantita-
ion of regurgitation, valve geometry, and load dependence
9,10). Nonetheless, there are some problems with the
tudy. Dobutamine stress produces an inotropic and vaso-
ilator response that is nonphysiological and may emphasize
V performance including myocardial viability. Exercise,
ather than dobutamine, is a preferable stressor for the
ssessment of valve lesions; indeed, the use of dobutamine
ather than exercise may explain why impairment of 6-min
alk distance correlated better with the resting than the
tress hemodynamics in this study.
As is often the case in studies of ischemic MR, the group
as very selected, with the 24 patients representing about
alf of the patients undergoing restrictive annuloplasty over
he study duration. Moreover, the control group is not
erfectly matched with patients with mitral regurgitation.
iven the differences in LV loading, the presence of a
imilar ejection fraction preoperatively suggests that the MR
atients actually had a worse ventricle to begin with. This
ay be very relevant, as the degree of scarring is a determi-
ant of LV compliance, which could be an important
ontributor to the transmitral gradient. In this context, it is
eassuring to find that the correlation of mitral gradient with
ulmonary artery pressure was better than the correlation
f total compliance, which accounts for the resistance of
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April 29, 2008:1702–3 Editorial Commentoth the mitral valve and LV to filling. Finally, left atrial
haracteristics may be an important contributor to the LV
lling pattern, and left atrial volume measurements would
e preferable to left atrial area, as the left atrium does not
niformly increase in size in all dimensions.
What should we conclude from this study? First, the
esults should highlight the fact that there is no place for
omplacency in the search for a surgical solution to
schemic MR and that the matter is far from solved.
econd, the findings argue against calls for even more
estrictive mitral annuloplasty, as post-stress mitral gra-
ients in patients with restrictive annuloplasty in this
tudy are already similar to those in mitral stenosis (11).
his suggests that whatever gains are obtained in the
eduction of recurrent MR by even more restrictive
nnuloplasties, they are likely to be lost by the introduc-
ion of mitral stenosis. Third, and controversially, the
esults warrant further consideration of the use of mitral
alve replacement, because the peak stress gradients are similar
r even less following mitral valve replacement than with
estrictive annuloplasty (12). Nonetheless, it is important to
cknowledge that a direct comparison against mitral valve
eplacement has not been performed in this study, and that
here are risks of valve replacement, including anticoagulation,
eoperation, patient-prosthesis mismatch, and adverse effects
n LV function, that still make this an undesirable interven-
ion. Finally, these results should encourage us to further
onsider the contributions of newer approaches such as cardiac
esynchronization therapy (13) and new techniques for over-
oming the alterations of LV shape that drive this process (1).
eprint requests and correspondence: Prof. Thomas H. Mar-
ick, University of Queensland Department of Medicine, Princess
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